Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC plus Naltrexone for Methamphetamine Dependence
NCT00332605Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jun 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, acetylcysteine in methamphetamine use disorder (MUD), sponsored by University of Chicago. Started Jun 2006; status: completed.
02
Drugs
naltrexoneacetylcysteine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00332605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332605.